BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16610763)

  • 21. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans.
    Wilkins C; Dishongh R; Moore SC; Whitt MA; Chow M; Machaca K
    Nature; 2005 Aug; 436(7053):1044-7. PubMed ID: 16107852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
    Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
    Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential therapeutic for pandemic influenza using RNA interference.
    Seth S; Templin MV; Severson G; Baturevych O
    Methods Mol Biol; 2010; 623():397-422. PubMed ID: 20217566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-mediated gene silencing: mechanisms and its therapeutic applications.
    Verma NK; Dey CS
    J Clin Pharm Ther; 2004 Oct; 29(5):395-404. PubMed ID: 15482382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the mammalian immune system by siRNAs.
    Marques JT; Williams BR
    Nat Biotechnol; 2005 Nov; 23(11):1399-405. PubMed ID: 16273073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of gene expression by siRNA in hematopoietic cells.
    Scherr M; Eder M
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.
    de Fougerolles A; Manoharan M; Meyers R; Vornlocher HP
    Methods Enzymol; 2005; 392():278-96. PubMed ID: 15644187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNA for gene silencing: a route to drug target discovery.
    Jones SW; Souza PM; Lindsay MA
    Curr Opin Pharmacol; 2004 Oct; 4(5):522-7. PubMed ID: 15351359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of potential antiviral strategy against coxsackievirus B4.
    Tan EL; Wong AP; Poh CL
    Virus Res; 2010 Jun; 150(1-2):85-92. PubMed ID: 20214933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-phase synthesis of siRNA oligonucleotides.
    Beaucage SL
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):203-16. PubMed ID: 18283608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA Silencing in the struggle against disease.
    Patzel V; Dietrich I; Kaufmann SH
    Ann N Y Acad Sci; 2006 Oct; 1082():44-6. PubMed ID: 17145923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic applications of RNAi for silencing virus replication.
    Tripp RA; Tompkins SM
    Methods Mol Biol; 2009; 555():43-61. PubMed ID: 19495687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(4):335-49. PubMed ID: 17146945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
    Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
    Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA technology.
    Schütze N
    Mol Cell Endocrinol; 2004 Jan; 213(2):115-9. PubMed ID: 15062558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [RNA interference as antiviral strategy].
    Neumann-Haefelin C; Blum HE; Thimme R
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2407-9. PubMed ID: 18988133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.